Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8689194 | Neurología | 2017 | 7 Pages |
Abstract
ROHHAD syndrome is a rare and little-known disease which requires a multidisciplinary approach because it involves complex symptoms and multiple organ system involvement. Alveolar hypoventilation should be identified early and appropriate treatment should be started promptly for the best possible outcome. Immunomodulatory treatment with immunoglobulins, cyclophosphamide, or rituximab has previously resulted in symptom improvement in some cases. Because of the low incidence of the syndrome, multi-centre studies must be carried out in order to gather more accurate information about ROHHAD pathophysiology and design an appropriate therapeutic approach.
Keywords
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
S. Ibáñez-Micó, A.M. Marcos Oltra, S. de Murcia Lemauviel, R. Ruiz Pruneda, C. MartÃnez Ferrández, R. Domingo Jiménez,